dc.contributor.author | Hawkins, Naomi | en_GB |
dc.date.accessioned | 2013-03-01T11:44:04Z | en_GB |
dc.date.accessioned | 2013-03-20T16:57:01Z | |
dc.date.issued | 2011-04 | en_GB |
dc.description.abstract | This article reports the results of an empirical study examining the impact of human gene patents on the development and delivery of genetic tests in the public sector in the United Kingdom. | en_GB |
dc.identifier.citation | Vol. 13, Issue 4, pp. 320 - 324 | en_GB |
dc.identifier.doi | 10.1097/GIM.0b013e3181fc50bc | en_GB |
dc.identifier.uri | http://hdl.handle.net/10036/4385 | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Nature Publishing Group | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/21150786 | en_GB |
dc.relation.url | http://www.nature.com/gim/index.html | en_GB |
dc.subject | Genetic Testing | en_GB |
dc.subject | Great Britain | en_GB |
dc.subject | Humans | en_GB |
dc.subject | Patents as Topic | en_GB |
dc.title | The impact of human gene patents on genetic testing in the United Kingdom | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2013-03-01T11:44:04Z | en_GB |
dc.date.available | 2013-03-20T16:57:01Z | |
dc.identifier.issn | 1098-3600 | en_GB |
exeter.place-of-publication | United States | en_GB |
dc.identifier.eissn | 1530-0366 | en_GB |
dc.identifier.journal | Genetics in Medicine | en_GB |